1C3B | A:; B: | AMPC BETA-LACTAMASE FROM E. COLI COMPLEXED WITH INHIBITOR, BENZO(B) THIOPHENE-2-BORONIC ACID (BZB) |
1FCM | A:; B: | CRYSTAL STRUCTURE OF THE E.COLI AMPC BETA-LACTAMASE MUTANT Q120L/Y150E COVALENTLY ACYLATED WITH THE INHIBITORY BETA-LACTAM, CLOXACILLIN |
1FCN | A:; B: | CRYSTAL STRUCTURE OF THE E. COLI AMPC BETA-LACTAMASE MUTANT Q120L/Y150E COVALENTLY ACYLATED WITH THE SUBSTRATE BETA-LACTAM LORACARBEF |
1FCO | A:; B: | CRYSTAL STRUCTURE OF THE E. COLI AMPC BETA-LACTAMASE COVALENTLY ACYLATED WITH THE INHIBITORY BETA-LACTAM, MOXALACTAM |
1FSW | A:; B: | AMPC BETA-LACTAMASE FROM E. COLI COMPLEXED WITH INHIBITOR CEPHALOTHINBORONIC ACID |
1FSY | A:; B: | AMPC BETA-LACTAMASE FROM E. COLI COMPLEXED WITH INHIBITOR CLOXACILLINBORONIC ACID |
1GA9 | A:; B: | CRYSTAL STRUCTURE OF AMPC BETA-LACTAMASE FROM E. COLI COMPLEXED WITH NON-BETA-LACTAMASE INHIBITOR (2, 3-(4-BENZENESULFONYL-THIOPHENE-2-SULFONYLAMINO)-PHENYLBORONIC ACID) |
1I5Q | A:; B: | CRYSTAL STRUCTURE OF THE E. COLI AMPC BETA-LACTAMASE MUTANT N152A COVALENTLY ACYLATED WITH THE INHIBITORY BETA-LACTAM, MOXALACTAM |
1IEL | A:; B: | CRYSTAL STRUCTURE OF AMPC BETA-LACTAMASE FROM E. COLI IN COMPLEX WITH CEFTAZIDIME |
1IEM | A:; B: | CRYSTAL STRUCTURE OF AMPC BETA-LACTAMASE FROM E. COLI IN COMPLEX WITH A BORONIC ACID INHIBITOR (1, CEFB4) |
1KDS | A:; B: | X-RAY CRYSTAL STRUCTURE OF AMPC BETA-LACTAMASE FROM E. COLI IN COMPLEX WITH THE INHIBITOR 3-NITROPHENYLBORONIC ACID |
1KDW | A:; B: | X-RAY CRYSTAL STRUCTURE OF AMPC BETA-LACTAMASE FROM E. COLI IN COMPLEX WITH THE INHIBITOR 4-CARBOXYPHENYLBORONIC ACID |
1KE0 | A:; B: | X-RAY CRYSTAL STRUCTURE OF AMPC BETA-LACTAMASE FROM E. COLI IN COMPLEX WITH THE INHIBITOR 4-(CARBOXYVIN-2-YL) PHENYLBORONIC ACID |
1KE3 | A:; B: | X-RAY CRYSTAL STRUCTURE OF AMPC BETA-LACTAMASE FROM E. COLI IN COMPLEX WITH THE INHIBITOR 4,4'-BIPHENYLDIBORONIC ACID |
1KE4 | A:; B: | X-RAY CRYSTAL STRUCTURE OF AMPC BETA-LACTAMASE FROM E. COLI |
1KVL | A:; B: | X-RAY CRYSTAL STRUCTURE OF AMPC S64G MUTANT BETA-LACTAMASE IN COMPLEX WITH SUBSTRATE AND PRODUCT FORMS OF CEPHALOTHIN |
1KVM | A:; B: | X-RAY CRYSTAL STRUCTURE OF AMPC WT BETA-LACTAMASE IN COMPLEX WITH COVALENTLY BOUND CEPHALOTHIN |
1L0D | A:; B: | X-RAY CRYSTAL STRUCTURE OF AMPC S64D MUTANT BETA-LACTAMASE |
1L0E | A:; B: | X-RAY CRYSTAL STRUCTURE OF AMPC K67Q MUTANT BETA-LACTAMASE |
1L0F | A:; B: | X-RAY CRYSTAL STRUCTURE OF AMPC N152H MUTANT BETA-LACTAMASE |
1L0G | A:; B: | X-RAY CRYSTAL STRUCTURE OF AMPC S64G MUTANT BETA-LACTAMASE |
1L2S | A:; B: | X-RAY CRYSTAL STRUCTURE OF AMPC BETA-LACTAMASE FROM E. COLI IN COMPLEX WITH A DOCK-PREDICTED NON-COVALENT INHIBITOR |
1LL5 | A:; B: | X-RAY CRYSTAL STRUCTURE OF AMPC WT BETA-LACTAMASE IN COMPLEX WITH COVALENTLY BOUND IMIPENEM |
1LL9 | A:; B: | CRYSTAL STRUCTURE OF AMPC BETA-LACTAMASE FROM E. COLI IN COMPLEX WITH AMOXICILLIN |
1LLB | A:; B: | CRYSTAL STRUCTURE OF AMPC BETA-LACTAMASE FROM E. COLI IN COMPLEX WITH ATMO-PENICILLIN |
1MXO | A:; B: | AMPC BETA-LACTAMASE IN COMPLEX WITH AN M.CARBOXYPHENYLGLYCYLBORONIC ACID BEARING THE CEPHALOTHIN R1 SIDE CHAIN |
1MY8 | A:; B: | AMPC BETA-LACTAMASE IN COMPLEX WITH AN M.CARBOXYPHENYLGLYCYLBORONIC ACID BEARING THE CEPHALOTHIN R1 SIDE CHAIN |
1O07 | A:; B: | CRYSTAL STRUCTURE OF THE COMPLEX BETWEEN Q120L/Y150E MUTANT OF AMPC AND A BETA-LACTAM INHIBITOR (MXG) |
1PI4 | A:; B: | STRUCTURE OF N289A MUTANT OF AMPC IN COMPLEX WITH SM3, A PHENYLGLYCLBORONIC ACID BEARING THE CEPHALOTHIN R1 SIDE CHAIN |
1PI5 | A:; B: | STRUCTURE OF N289A MUTANT OF AMPC IN COMPLEX WITH SM2, CARBOXYPHENYLGLYCYLBORONIC ACID BEARING THE CEPHALOTHIN R1 SIDE CHAIN |
1XGI | A:; B: | AMPC BETA-LACTAMASE IN COMPLEX WITH 3-(3-NITRO-PHENYLSULFAMOYL)-THIOPHENE-2-CARBOXYLIC ACID |
1XGJ | A:; B: | AMPC BETA-LACTAMASE IN COMPLEX WITH 3-(4-CARBOXY-2-HYDROXY-PHENYLSULFAMOYL)-THIOPHENE-2-CARBOXYLIC ACID |
2BLS | A:; B: | AMPC BETA-LACTAMASE FROM ESCHERICHIA COLI |
2FFY | A:; B: | AMPC BETA-LACTAMASE N289A MUTANT IN COMPLEX WITH A BORONIC ACID DEACYLATION TRANSITION STATE ANALOG COMPOUND SM3 |
2HDQ | A:; B: | AMPC BETA-LACTAMASE IN COMPLEX WITH 2-CARBOXYTHIOPHENE |
2HDR | A:; B: | AMPC BETA-LACTAMASE IN COMPLEX WITH 4-AMINO-3-HYDROXYBENZOIC ACID |
2HDS | A:; B: | AMPC BETA-LACTAMASE IN COMPLEX WITH 4-METHANESULFONYLAMINO BENZOIC ACID |
2HDU | A:; B: | AMPC BETA-LACTAMASE IN COMPLEX WITH 2-ACETAMIDOTHIOPHENE-3-CARBOXYLIC ACID |
2I72 | A:; B: | AMPC BETA-LACTAMASE IN COMPLEX WITH 5-DIFORMYLAMINOMETHYL-BENZO[B]THIOPHEN-2-BORONIC ACID |
2P9V | A:; B: | STRUCTURE OF AMPC BETA-LACTAMASE WITH CROSS-LINKED ACTIVE SITE AFTER EXPOSURE TO SMALL MOLECULE INHIBITOR |
2PU2 | A:; B: | AMPC BETA-LACTAMASE WITH BOUND PHTHALAMIDE INHIBITOR |
2PU4 | A:; B: | AMPC BETA-LACAMASE WITH BOUND COVALENT OXADIAZOLE INHIBITOR |
2R9W | A:; B: | AMPC BETA-LACTAMASE WITH BOUND PHTHALAMIDE INHIBITOR |
2R9X | A:; B: | AMPC BETA-LACTAMASE WITH BOUND PHTHALAMIDE INHIBITOR |
2RCX | A:; B: | AMPC BETA-LACTAMASE IN COMPLEX WITH (1R)-1-(2-THIOPHEN-2-YL-ACETYLAMINO)-1-(3-(2-CARBOXYVINYL)-PHENYL) METHYLBORONIC ACID |
3BLS | A:; B: | AMPC BETA-LACTAMASE FROM ESCHERICHIA COLI |
3BM6 | A:; B: | AMPC BETA-LACTAMASE IN COMPLEX WITH A P.CARBOXYPHENYLBORONIC ACID |
3FKV | A:; B: | AMPC K67R MUTANT COMPLEXED WITH BENZO(B)THIOPHENE-2-BORONIC ACID (BZB) |
3FKW | A:; B: | AMPC K67R MUTANT APO STRUCTURE |
3GQZ | A:; B: | AMPC BETA-LACTAMASE IN COMPLEX WITH FRAGMENT-BASED INHIBITOR |
3GR2 | A:; B: | AMPC BETA-LACTAMASE IN COMPLEX WITH FRAGMENT-BASED INHIBITOR |
3GRJ | A:; B: | AMPC BETA-LACTAMASE IN COMPLEX WITH FRAGMENT-BASED INHIBITOR |
3GSG | A:; B: | AMPC BETA-LACTAMASE IN COMPLEX WITH FRAGMENT-BASED INHIBITOR |
3GTC | A:; B: | AMPC BETA-LACTAMASE IN COMPLEX WITH FRAGMENT-BASED INHIBITOR |
3GV9 | A:; B: | AMPC BETA-LACTAMASE IN COMPLEX WITH FRAGMENT-BASED INHIBITOR |
3GVB | A:; B: | AMPC BETA-LACTAMASE IN COMPLEX WITH FRAGMENT-BASED INHIBITOR |
3IWI | A:; B: | X-RAY CRYSTAL STRUCTURE OF THE EXTENDED-SPECTRUM AMPC OMEGA LOOP INSERTION (H210AAA) MUTANT BETA-LACTAMASE AT 1.64 ANGSTROM RESOLUTION |
3IWO | A:; B: | X-RAY CRYSTAL STRUCTURE OF THE EXTENDED-SPECTRUM AMPC Y221G MUTANT BETA-LACTAMASE AT 1.90 ANGSTROM RESOLUTION |
3IWQ | A:; B: | X-RAY CRYSTAL STRUCTURE OF THE EXTENDED-SPECTRUM AMPC E219K MUTANT BETA-LACTAMASE AT 1.84 ANGSTROM RESOLUTION |
3IXB | A:; B: | X-RAY CRYSTAL STRUCTURE OF THE EXTENDED-SPECTRUM AMPC E219K MUTANT BETA-LACTAMASE COMPLEXED WITH BENZO(B)THIOPHENE-2-BORONIC ACID (BZB) AT 1.63 ANGSTROM RESOLUTION |
3IXD | A:; B: | X-RAY CRYSTAL STRUCTURE OF THE EXTENDED-SPECTRUM AMPC V298E MUTANT BETA-LACTAMASE AT 2.64 ANGSTROM RESOLUTION |
3IXG | A:; B: | X-RAY CRYSTAL STRUCTURE OF THE EXTENDED-SPECTRUM AMPC T70I MUTANT BETA-LACTAMASE WITH AND WITHOUT BENZO(B)THIOPHENE-2-BORONIC ACID BOUND AT 2.14 ANGSTROM RESOLUTION |
3IXH | A:; B: | X-RAY CRYSTAL STRUCTURE OF THE EXTENDED-SPECTRUM AMPC Y221G MUTANT BETA-LACTAMASE IN COMPLEX WITH CEFOTAXIME AT 2.3 ANGSTROM RESOLUTION |
3O86 | A:; B: | CRYSTAL STRUCTURE OF AMPC BETA-LACTAMASE IN COMPLEX WITH A SULFONAMIDE BORONIC ACID INHIBITOR |
3O87 | A:; B: | CRYSTAL STRUCTURE OF AMPC BETA-LACTAMASE IN COMPLEX WITH A SULFONAMIDE BORONIC ACID INHIBITOR |
3O88 | A:; B: | CRYSTAL STRUCTURE OF AMPC BETA-LACTAMASE IN COMPLEX WITH A SULFONAMIDE BORONIC ACID INHIBITOR |
4E3I | A:; B: | CRYSTAL STRUCTURE OF AMPC BETA-LACTAMASE IN COMPLEX WITH A DESIGNED 3-CARBOXYL BENZYL SULFONAMIDE BORONIC ACID INHIBITOR |
4E3J | A:; B: | CRYSTAL STRUCTURE OF AMPC BETA-LACTAMASE IN COMPLEX WITH A DESIGNED 4-TETRAZOLYL BENZENE SULFONAMIDE BORONIC ACID INHIBITOR |
4E3K | A:; B: | CRYSTAL STRUCTURE OF AMPC BETA-LACTAMASE IN COMPLEX WITH A DESIGNED 4-TETRAZOLYL PYRIDINE SULFONAMIDE BORONIC ACID INHIBITOR |
4E3L | A:; B: | CRYSTAL STRUCTURE OF AMPC BETA-LACTAMASE IN COMPLEX WITH A 3-CHLORO-4-TETRAZOLYL BENZENE SULFONAMIDE BORONIC ACID INHIBITOR |
4E3M | A:; B: | CRYSTAL STRUCTURE OF AMPC BETA-LACTAMASE IN COMPLEX WITH A 2-CHLORO-4-TETRAZOLYL BENZENE SULFONAMIDE BORONIC ACID INHIBITOR |
4E3N | A:; B: | CRYSTAL STRUCTURE OF AMPC BETA-LACTAMASE IN COMPLEX WITH A 2-TRIFLUOROMETHYL-4-TETRAZOLYL BENZENE SULFONAMIDE BORONIC ACID INHIBITOR |
4E3O | A:; B: | CRYSTAL STRUCTURE OF AMPC BETA-LACTAMASE IN COMPLEX WITH A SMALL CHLOROMETHYL SULFONAMIDE BORONIC ACID INHIBITOR |